The CTLA-4 x OX40 bispecific antibody ATOR-1015 induces anti-tumor effects through tumor-directed immune activation. (Record no. 29578975)
[ view plain ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 02103 a2200637 4500 |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20250518033432.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
| fixed length control field | 202007s 0 0 eng d |
| 022 ## - INTERNATIONAL STANDARD SERIAL NUMBER | |
| International Standard Serial Number | 2051-1426 |
| 024 7# - OTHER STANDARD IDENTIFIER | |
| Standard number or code | 10.1186/s40425-019-0570-8 |
| Source of number or code | doi |
| 040 ## - CATALOGING SOURCE | |
| Original cataloging agency | NLM |
| Language of cataloging | eng |
| Transcribing agency | NLM |
| 100 1# - MAIN ENTRY--PERSONAL NAME | |
| Personal name | Kvarnhammar, Anne Månsson |
| 264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
| Date of production, publication, distribution, manufacture, or copyright notice | 20200707 |
| 245 00 - TITLE STATEMENT | |
| Title | The CTLA-4 x OX40 bispecific antibody ATOR-1015 induces anti-tumor effects through tumor-directed immune activation. |
| Medium | [electronic resource] |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
| Name of publisher, distributor, etc. | Journal for immunotherapy of cancer |
| Date of publication, distribution, etc. | 04 2019 |
| 300 ## - PHYSICAL DESCRIPTION | |
| Extent | 103 p. |
| Other physical details | digital |
| 500 ## - GENERAL NOTE | |
| General note | Publication Type: Journal Article; Research Support, Non-U.S. Gov't |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Animals |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Antibodies, Bispecific |
| General subdivision | pharmacology |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | CHO Cells |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | CTLA-4 Antigen |
| General subdivision | antagonists & inhibitors |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Cell Line, Tumor |
| General subdivision | transplantation |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Cricetulus |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Disease Models, Animal |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Drug Screening Assays, Antitumor |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Female |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | HEK293 Cells |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Humans |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Male |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Mice |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Mice, Transgenic |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Primary Cell Culture |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Proof of Concept Study |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Receptors, OX40 |
| General subdivision | agonists |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | T-Lymphocytes, Regulatory |
| General subdivision | drug effects |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Urinary Bladder Neoplasms |
| General subdivision | drug therapy |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Veitonmäki, Niina |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Hägerbrand, Karin |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Dahlman, Anna |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Smith, Karin Enell |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Fritzell, Sara |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | von Schantz, Laura |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Thagesson, Mia |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Werchau, Doreen |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Smedenfors, Kristine |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Johansson, Maria |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Rosén, Anna |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Åberg, Ida |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Winnerstam, Magnus |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Nyblom, Eva |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Barchan, Karin |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Furebring, Christina |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Norlén, Per |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Ellmark, Peter |
| 773 0# - HOST ITEM ENTRY | |
| Title | Journal for immunotherapy of cancer |
| Related parts | vol. 7 |
| -- | no. 1 |
| -- | p. 103 |
| 856 40 - ELECTRONIC LOCATION AND ACCESS | |
| Uniform Resource Identifier | <a href="https://doi.org/10.1186/s40425-019-0570-8">https://doi.org/10.1186/s40425-019-0570-8</a> |
| Public note | Available from publisher's website |
No items available.